Welcome to Granulab
GranuLab (M) Sdn Bhd - a BioNexus Status Company (BNX 100217), was established since May 2006. It is a medical device manufacturing company for synthetic bone graft GranuMas®. Granulab is a subsidiary of SIRIM Tech Venture (STV), a company wholly owned by SIRIM Berhad. Granulab manufacturing facility is certified with ISO 13485:2003 by BSI, UK. The facility is well equipped and capable of producing multiple types, form, shape and size of synthetic bone grafts to cater to the needs of clients, hospitals and patients.
Prior to its commercialization, GranuMaS had successfully passed all the necessary in vitro and in vivo biocompatibility tests for cytotoxicity, genotoxicity, serologic, and sterilization; including animals and humans clinical studies; for both dental and orthopaedic applications based on the required criteria as set by ISO 10993 and FDA matrices.
Granulab takes product performance and effectiveness as well as patient safety to be at the highest priority. We are committed to apply continual improvement and risk management in accordance with industrial standards.